Wednesday, June 17, 2009

CeNeRx BioPharma Obtains Rights To Novel Drug Candidate For Prevention And Treatment Of Neurodegeneration Disorders

CeNeRx BioPharma Obtains Rights To Novel Drug Candidate For Prevention And Treatment Of Neurodegeneration Disorders

Medical News Today, Article Date: 17 Jun 2009 - 3:00 PDT

Full Text: http://www.medicalnewstoday.com/articles/154197.php

Keywords: central nervous system , neuropathies, neurodegenerative disorders, CXB909, nerve growth factor (NGF), Phase l trial , blood brain barrier.

Press realease of CeNeRx Biopharma: http://cenerx.com/News/releases/16a-JUN-09.pdf

Tuesday, June 16, 2009

DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice

J. Clin. Invest. doi:10.1172/JCI39038

Copyright © 2009, The American Society for Clinical Investigation



DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice


Tomoya Terashima1, Kazuhiro Oka1,2, Angelika B. Kritz3, Hideto Kojima2, Andrew H. Baker3 and Lawrence Chan1,2
1Department of Medicine and 2Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA. 3British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Address correspondence to: Lawrence Chan, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA. Phone: (713) 798-4478; Fax: (713) 798-8764; E-mail: lchan@bcm.tmc.edu.



Published June 15, 2009



Full text: http://www.jci.org/articles/view/39038



Keywords: sensory neuronopathies, painful , DRG, therapeutic genes , dorsal root ganglion , adenoviruses, mice.

Therapeutic Delivery Of A Gene To Dysfunctional Nerves

Therapeutic Delivery Of A Gene To Dysfunctional Nerves

ScienceDaily (June 15, 2009) — In many sensory neuronopathies, painful conditions affecting sensory nerves outside the brain and spinal cord, the affected nerves are in a region known as the DRG. These conditions are difficult to treat. However, researchers have now developed an approach to target therapeutic genes to DRG nerves, and used it to reduce sensory nerve dysfunction in a mouse model of Sandhoff disease, an inherited condition in which many nerves, including those in the DRG, are affected.

Full Text http://www.sciencedaily.com/releases/2009/06/090615171509.htm

Keywords: sensory neuronopathies, painful , DRG, therapeutic genes , dorsal root ganglion , adenoviruses, mice.

Saturday, June 13, 2009

Fine Mapping of Gene Regions Regulating Neurodegeneration

OPEN ACCES

PLoS ONE, Full text

Fine Mapping of Gene Regions Regulating Neurodegeneration

Maria Swanberg1,2, Karin Harnesk1#, Mikael Ström1#, Margarita Diez1, Olle Lidman1, Fredrik Piehl1*

1 Department of Clinical Neuroscience, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden, 2 Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden

Abstract

Background

Damage to nerve cells and axons leading to neurodegeneration is a characteristic feature of many neurological diseases. The degree of genetic influence on susceptibility to axotomy-induced neuronal death has so far been unknown. We have examined two gene regions, Vra1 and Vra2, previously linked to nerve cell loss after ventral root avulsion in a rat F2 intercross between the DA and PVG inbred rat strains.

Methodology/Principal Findings

In this study, we use two generations (G8 and G10 cohorts) of an advanced intercross line between DA and PVGav1 to reproduce linkage to Vra1 and to fine-map this region. By isolating the effect from Vra1 in congenic strains, we demonstrate that Vra1 significantly regulates the loss of motoneurons after avulsion. The regulatory effect mediated by Vra1 thus resides in a congenic fragment of 9 megabases. Furthermore, we have used the advanced intercross lines to give more support to Vra2, originally detected as a suggestive QTL.

Conclusions/Significance

The results demonstrated here show that naturally occurring allelic variations affect susceptibility to axotomy-induced nerve cell death. Vra1 and Vra2 represent the first quantitative trait loci regulating this phenotype that are characterized and fine mapped in an advanced intercross line. In addition, congenic strains provide experimental evidence for the Vra1 effect on the extent of injury-induced neurodegeneration. Identification of the underlying genetic variations will increase our understanding of the regulation and mechanisms of neurodegeneration.

Thursday, June 11, 2009

Two Signals -- From Within And Out Of Cell -- Specify Motor Neuron Differentiation

ScienceDaily (June 10, 2009) -Science News

Two Signals -- From Within And Out Of Cell -- Specify Motor Neuron Differentiation

ScienceDaily (June 10, 2009) — Two signals – an external one from retinoic acid and an internal one from the transcription factor Neurogenin2 – cooperate to activate chromatin (the basic material of chromosomes) and help determine that certain nerve progenitor cells become motor neurons, said researchers from Baylor College of Medicine in a report in the current issue of the journal Neuron.

Full text: http://www.sciencedaily.com/releases/2009/06/090610124411.htm

Keywords: motor neurons , stem cells, Neurogenin2, retinoic acid , histone acetyltransferase , histones , transcription , nerve progenitor cells, muscular dystrophies

Saturday, June 6, 2009

Oligomeric yeast frataxin drives assembly of core machinery for mitochondrial iron-sulfur cluster synthesis.

J Biol Chem. 2009 Jun 2.

Oligomeric yeast frataxin drives assembly of core machinery for mitochondrial iron-sulfur cluster synthesis.


Li H, Gakh O, Smith DY 4th, Isaya G.

Mayo Clinic, College of Medicine, United States.

Mitochondrial biosynthesis of iron-sulfur clusters (ISC)(1) is a vital process involving the delivery of elemental iron and sulfur to a scaffold protein .....

Keywords: iron-sulfur clusters, iron, sulfur, Yfh1, Nfs1-Isd11, Isu1, oligomerization, oxidation, mechanism, mitochondrial ISC synthesis..

Neural stem cell boosting chemical that generate new neurons - received U.S. patent allowance

"Stem Cell Research Blog" 06 Jun 2009 12:43 pm

Neural-stem-cell-boosting-chemical-that-generate-new-neurons-received-us-patent-allowance

The U.S. Patent and Trademark Office (USPTO) have delivered a notice of allowance to Neuralstem, Inc. for a patent on four new chemicals that can boost the generation of new neurons. .....

Keywords: Neuralstem Inc, patent, neurons, neurogenic activity, drugs, human neural stem cells, hippocampus.

Friday, June 5, 2009

Subjective Improvement in Proprioception in 2 Patients With Atypical Friedreich Ataxia Treated With Varenicline (Chantix)

Journal of Clinical Neuromuscular Disease:
June 2009 - Volume 10 - Issue 4 - pp 191-193
doi: 10.1097/CND.0b013e3181910074

Subjective Improvement in Proprioception in 2 Patients With Atypical Friedreich Ataxia Treated With Varenicline (Chantix)
Zesiewicz, Theresa A MD, FAAN; Sullivan, Kelly L MSPH; Gooch, Clifton L MD; Lynch, David R MD, PhD

Keywords: Friedreich ataxia , proprioceptive improvements , varenicline (Chantix), smoking cessation.

Thursday, June 4, 2009

Small Molecules Mimic Natural Gene Regulators

Medical News Today: Article Date: 04 Jun 2009 - 7:00 PDT
Source: Nancy Ross-Flanigan. University of Michigan

Small Molecules Mimic Natural Gene Regulators

In the quest for new approaches to treating and preventing disease, one appealing route involves turning genes .......

.../...
These molecules can help scientists probe the transcription process and perhaps eventually be used to correct diseases that result from errors in gene regulation.
.../...

Keywords: turning genes, cancer, diabetes, gene expression, transcriptional activators , CBP.

Original work:( http://pubs.acs.org/doi/abs/10.1021/cb900028j?prevSearch=David+Wemmer&searchHistoryKey= )

Amphipathic Small Molecules Mimic the Binding Mode and Function of Endogenous Transcription Factors

Sara J. Buhrlage†, Caleb A. Bates‡, Steven P. Rowe†, Aaron R. Minter†, Brian B. Brennan†, Chinmay Y. Majmudar†, David E. Wemmer§, Hashim Al-Hashimi† and Anna K. Mapp†‡*
† Department of Chemistry ‡ Department of Medicinal Chemistry Department of Biophysics ¶ Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan, 48109 § Department of Chemistry, University of California, Berkeley, California 94720
ACS Chem. Biol., 2009, 4 (5), pp 335–344
DOI: 10.1021/cb900028j
Publication Date (Web): April 6, 2009
Copyright © 2009 American Chemical Society


Wednesday, June 3, 2009

Friedreich ataxia (fa) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy.

Friedreich ataxia (fa) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy.

Bosn J Basic Med Sci. 2009 May;9(2):107-10.

Gucev Z, Tasic V, Jancevska A, Popjordanova N, Koceva S, Kuturec M, Sabolic V.
Faculty of Medicine Skopje, St. Cyril and Methodius University, 50 Divizija BB, 1000 Skopje, Macedonia.

Progressive signs of ataxia in a eight years old girl prompted neurological investigation. The girl had unstable gait .....

Keywords: Friedreich ataxia, dysarthria, pes cavus, positive Babinski sign, scoliosis, diabetic ketoacidosis, GAA trinucleotide repeat, sinus bradycardia, hyperthrophic cardiomyopathy, beta blocker, insulin.